The momentous biological mediators of COPD are pro-inflammatory cytokines including TNF-α and IL-1β, which are found to be memorably increased in COPD patients and released by massive inflammatory cells in response to CS treatment (Rahman and Adcock, 2006). This evidence concerns the gene IL1B and chronic obstructive pulmonary disease.